Management of Age-Related Osteoporosis and Prevention of Associated Fractures

References

• AaronJEGallagherJCAndersonJFrequency of osteomalacia and osteoporosis in fractures of the proximal femurLancet19741229334130245
   PubMed Web of Science ®Google Scholar
• AdamsJSKantorovichVWuCResolution of vitamin D insufficiency in osteopenic patients results in rapid recovery of bone mineral densityJ Clin Endocrinol Metab19998427293010443668
   PubMed Web of Science ®Google Scholar
• AminSFelsonDTOsteoporosis in menRheum Dis Clin North Am200127194711285995
   PubMed Web of Science ®Google Scholar
• Bischoff-FerrariHADietrichTOravEJPositive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adultsAm J Med2004116634915093761
   PubMed Web of Science ®Google Scholar
• Bischoff-FerrariHAWillettWCWongJBFracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trialsJAMA200529322576415886381
   PubMed Web of Science ®Google Scholar
• BlackDMBilezikianJPEnsrudKEOne year of alendronate after one year of parathyroid hormone (1-84) for osteoporosisN Engl J Med20053535556516093464
   PubMed Web of Science ®Google Scholar
• BlackDMGreenspanSLEnsrudKEThe effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosisN Engl J Med200334912071514500804
   PubMed Web of Science ®Google Scholar
• BlackDMThompsonDEBauerDCFracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research GroupJ Clin Endocrinol Metab20008541182411095442
   PubMed Web of Science ®Google Scholar
• BoneHGGreenspanSLMcKeeverCAlendronate and estrogen effects in postmenopausal women with low bone mineral densityJ Clin Endocrinol Metab200085720610690882
   PubMed Web of Science ®Google Scholar
• BrownJPKendlerDLMcClungMRThe efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosisCalcif Tissue Int2002711031112085156
   PubMed Web of Science ®Google Scholar
• CadaretteSMJaglalSBKreigerNDevelopment and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometryCMAJ200016212899410813010
   PubMed Web of Science ®Google Scholar
• CauleyJABlackDMBarrett-ConnorEEffects of hormone replacement therapy on clinical fractures and height loss: The Heart and Estrogen/Progestin Replacement Study (HERS)Am J Med20011104425011331055
   PubMed Web of Science ®Google Scholar
• CauleyJANortonLLippmanMEContinued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluationBreast Cancer Res Treat2001651253411261828
   PubMed Web of Science ®Google Scholar
• CauleyJARobbinsJChenZEffects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trialJAMA200329017293814519707
   PubMed Web of Science ®Google Scholar
• CenterJRNguyenTVSchneiderDMortality after all major types of osteoporotic fracture in men and women: an observational studyLancet19993538788210093980
   PubMed Web of Science ®Google Scholar
• ChapuyMCArlotMEDuboeufFVitamin D3 and calcium to prevent hip fractures in the elderly womenN Engl J Med19923271637421331788
   PubMed Web of Science ®Google Scholar
• ChesnutCH3rdSilvermanSAndrianoKA randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study GroupAm J Med20001092677610996576
   PubMed Web of Science ®Google Scholar
• ChesnutICSkagAChristiansenCEffects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosisJ Bone Miner Res2004191241915231010
   PubMed Web of Science ®Google Scholar
• CompstonJEPapapoulosSEBlanchardFReport on osteoporosis in the European Community: current status and recommendations for the future. Working Party from European Union Member StatesOsteoporos Int19988531410326056
   PubMed Web of Science ®Google Scholar
• CramerJAAmonkarMMHebbornACompliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosisCurr Med Res Opin20052114536016197664
   PubMed Web of Science ®Google Scholar
• CummingRGEpidemiology of medication-related falls and fractures in the elderlyDrugs Aging19981243539467686
   PubMed Web of Science ®Google Scholar
• CummingsSRBatesDBlackDMClinical use of bone densitometry: scientific reviewJAMA200228818899712377088
   PubMed Web of Science ®Google Scholar
• CummingsSRBlackDMNevittMCBone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research GroupLancet19933417258093403
   PubMed Web of Science ®Google Scholar
• CummingsSRBlackDMThompsonDEEffect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention TrialJAMA19982802077829875874
   PubMed Web of Science ®Google Scholar
• Dawson-HughesBHarrisSSKrallEAEffect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or olderN Engl J Med199733767069278463
   PubMed Web of Science ®Google Scholar
• DelmasPDBjarnasonNHMitlakBHEffects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal womenN Engl J Med1997337164179385122
   PubMed Web of Science ®Google Scholar
• DolanPTorgersonDJThe cost of treating osteoporotic fractures in the United Kingdom female populationOsteoporos Int199886111710326069
   PubMed Web of Science ®Google Scholar
• ElliottMEDrinkaPJKrausePOsteoporosis assessment strategies for male nursing home residentsMaturitas2004482253315207888
   PubMed Web of Science ®Google Scholar
• EmpanaJPDargent-MolinaPBreartGEffect of hip fracture on mortality in elderly women: the EPIDOS prospective studyJ Am Geriatr Soc2004526859015086646
   PubMed Web of Science ®Google Scholar
• EttingerBBlackDMMitlakBHReduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) InvestigatorsJAMA19992826374510517716
   PubMed Web of Science ®Google Scholar
• EttingerBEnsrudKEWallaceREffects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trialObstet Gynecol20041044435115339752
   PubMed Web of Science ®Google Scholar
• FarleyJRWergedalJEBaylinkDJFluoride directly stimulates proliferation and alkaline phosphatase activity of bone-forming cellsScience198322233026623079
   PubMed Web of Science ®Google Scholar
• FinkHAEnsrudKENelsonDBDisability after clinical fracture in postmenopausal women with low bone density: the fracture intervention trial (FIT)Osteoporos Int200314697612577187
   PubMed Web of Science ®Google Scholar
• FinkelsteinJSHayesAHunzelmanJLThe effects of parathyroid hormone, alendronate, or both in men with osteoporosisN Engl J Med200334912162614500805
   PubMed Web of Science ®Google Scholar
• GallagherJCGoldgarDTreatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled studyAnn Intern Med1990113649552221645
   PubMed Web of Science ®Google Scholar
• GradyDGebretsadikTKerlikowskeKHormone replacement therapy and endometrial cancer risk: a meta-analysisObstet Gynecol199585304137824251
   PubMed Web of Science ®Google Scholar
• GranekEBakerSPAbbeyHMedications and diagnoses in relation to falls in a long-term care facilityJ Am Geriatr Soc198735503113571802
   PubMed Web of Science ®Google Scholar
• GrantAMAvenellACampbellMKOral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trialLancet20053651621815885294
   PubMed Web of Science ®Google Scholar
• GreenspanSLResnickNMParkerRACombination therapy with hormone replacement and alendronate for prevention of bone loss in elderly women: a randomized controlled trialJAMA200328925253312759324
   PubMed Web of Science ®Google Scholar
• GruberHEIveyJLBaylinkDJLong-term calcitonin therapy in postmenopausal osteoporosisMetabolism1984332953036423929
   PubMed Web of Science ®Google Scholar
• HallbergIRosenqvistAMKartousLHealth-related quality of life after osteoporotic fracturesOsteoporos Int2004158344115045468
   PubMed Web of Science ®Google Scholar
• HarrisSTEriksenEFDavidsonMEffect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal womenJ Clin Endocrinol Metab2001861890711344179
   PubMed Web of Science ®Google Scholar
• HarrisSTWattsNBGenantHKEffects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study GroupJAMA199928213445210527181
   PubMed Web of Science ®Google Scholar
• HodsmanABBauerDCDempsterDParathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its useEndocr Rev20052668870315769903
   PubMed Web of Science ®Google Scholar
• HolickMFSirisESBinkleyNPrevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapyJ Clin Endocrinol Metab20059032152415797954
   PubMed Web of Science ®Google Scholar
• HulleySGradyDBushTRandomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research GroupJAMA1998280605139718051
   PubMed Web of Science ®Google Scholar
• JacksonRDLa CroixAZGassMCalcium plus vitamin D supplementation and the risk of fracturesN Engl J Med20063546698316481635
   PubMed Web of Science ®Google Scholar
• JohnellOKanisJAAn estimate of the worldwide prevalence, mortality and disability associated with hip fractureOsteoporos Int20041589790215490120
   PubMed Web of Science ®Google Scholar
• JohnellOScheeleWHLuYAdditive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosisJ Clin Endocrinol Metab2002879859211889149
   PubMed Web of Science ®Google Scholar
• KamelHKUnderutilization of calcium and vitamin D supplements in an academic long-term care facilityJ Am Med Dir Assoc200459810014984620
   PubMedGoogle Scholar
• KanisJAGluerCCAn update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis FoundationOsteoporos Int20001119220210824234
   PubMed Web of Science ®Google Scholar
• KannusPSievanenHPalvanenMPrevention of falls and consequent injuries in elderly peopleLancet200536618859316310556
   PubMed Web of Science ®Google Scholar
• [Lasofoxifene]Lasofoxifene: CP 336156, CP-336156Drugs R D20056566015801869
   PubMedGoogle Scholar
• Le BoffMSKohlmeierLHurwitzSOccult vitamin D deficiency in postmenopausal US women with acute hip fractureJAMA199928115051110227320
   PubMed Web of Science ®Google Scholar
• LewieckiEMWattsNBMcClungMROfficial positions of the international society for clinical densitometryJ Clin Endocrinol Metab2004893651515292281
   PubMed Web of Science ®Google Scholar
• LicataAADiscovery, clinical development, and therapeutic uses of bisphosphonatesAnn Pharmacother2005396687715755793
   PubMed Web of Science ®Google Scholar
• LindsayRGallagherJCKleerekoperMEffect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal womenJAMA200228726687612020302
   PubMed Web of Science ®Google Scholar
• LipsPCooperCAgnusdeiDQuality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for OsteoporosisOsteoporos Int1999101506010501796
   PubMed Web of Science ®Google Scholar
• LipsPGraafmansWCOomsMEVitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo-controlled clinical trialAnn Intern Med199612440068554248
   PubMed Web of Science ®Google Scholar
• LydickECookKTurpinJDevelopment and validation of a simple questionnaire to facilitate identification of women likely to have low bone densityAm J Manag Care19984374810179905
   PubMed Web of Science ®Google Scholar
• LyritisGPTsakalakosNMagiasisBAnalgesic effect of salmon calcitonin in osteoporotic vertebral fractures: a double-blind placebo-controlled clinical studyCalcif Tissue Int199149369721818759
   PubMed Web of Science ®Google Scholar
• MalabananAVeronikisIEHolickMFRedefining vitamin D insufficiencyLancet199835180569519960
   PubMed Web of Science ®Google Scholar
• MargolisDJKnaussJBilkerWMedical conditions as risk factors for pressure ulcers in an outpatient settingAge Ageing2003322596412720610
   PubMed Web of Science ®Google Scholar
• MariePJStrontium as therapy for osteoporosisCurr Opin Pharmacol20055633616183330
   PubMed Web of Science ®Google Scholar
• MarshallDJohnellOWedelHMeta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fracturesBMJ1996312125498634613
   PubMed Web of Science ®Google Scholar
• MartinoSDischDDowsettSASafety assessment of raloxifene over eight years in a clinical trial settingCurr Med Res Opin20052114415216197663
   PubMed Web of Science ®Google Scholar
• Mc ClungMRGeusensPMillerPDEffect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study GroupN Engl J Med20013443334011172164
   PubMed Web of Science ®Google Scholar
• MeunierPJRouxCSeemanEThe effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosisN Engl J Med20043504596814749454
   PubMed Web of Science ®Google Scholar
• MeunierPJSlosmanDODelmasPDStrontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis—a 2-year randomized placebo controlled trialJ Clin Endocrinol Metab2002872060611994341
   PubMed Web of Science ®Google Scholar
• MillerPDMc ClungMRMacoveiLMonthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE studyJ Bone Miner Res20052013152216007327
   PubMed Web of Science ®Google Scholar
• [NAS] National Academy of Sciences. Institute of Medicine, Food, and Nutrition BoardDietary reference intake tables: vitamins [online]1997 Accessed on 22 December 2005. URL: http://www.iom.edu/Object.File/Master/7/296/0.pdf
   Google Scholar
• NeedAGO’LoughlinPDMorrisHAThe effects of age and other variables on serum parathyroid hormone in postmenopausal women attending an osteoporosis centerJ Clin Endocrinol Metab2004891646915070925
   PubMed Web of Science ®Google Scholar
• NeerRMArnaudCDZanchettaJREffect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosisN Engl J Med200134414344111346808
   PubMed Web of Science ®Google Scholar
• NevittMCEttingerBBlackDMThe association of radiographically detected vertebral fractures with back pain and function: a prospective studyAnn Intern Med19981287938009599190
   PubMed Web of Science ®Google Scholar
• [NIH] NIH Consensus conferenceOptimal calcium intake. NIH Consensus Development Panel on Optimal Calcium IntakeJAMA1994272194287990248
   PubMed Web of Science ®Google Scholar
• [NIH] NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and TherapyOsteoporosis prevention, diagnosis, and therapyJAMA20012857859511176917
   PubMed Web of Science ®Google Scholar
• [NOF] National Osteoporosis FoundationPhysician's guide to prevention and treatment of osteoporosis [online]2004 Accessed on 23 March 2005 URL: http://www.nof.org/physguide/index.htm
   Google Scholar
• [NOF] National Osteoporosis FoundationAmerica's bone health: the state of osteoporosis and low bone mass [online]2005a Accessed on 16 November 2005. URL: http://www.nof.org/advocacy/prevalence/index.htm
   Google Scholar
• [NOF] National Osteoporosis FoundationOsteoporosis: fast facts [online]2005b Accessed on 15 November 2005. URL: http://www.nof.org/osteoporosis/diseasefacts.htm
   Google Scholar
• NotelovitzMEstrogen therapy and osteoporosis: principles & practiceAm J Med Sci19973132129001160
   PubMed Web of Science ®Google Scholar
• OrwollEEttingerMWeissSAlendronate for the treatment of osteoporosis in menN Engl J Med20003436041010979796
   PubMed Web of Science ®Google Scholar
• OrwollESScheeleWHPaulSThe effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosisJ Bone Miner Res20031891712510800
   PubMed Web of Science ®Google Scholar
• PavlovPWGinsburgJKicovicPMDouble-blind, placebo-controlled study of the effects of tibolone on bone mineral density in postmenopausal osteoporotic women with and without previous fracturesGynecol Endocrinol199913230710533157
   PubMed Web of Science ®Google Scholar
• ReginsterJMinneHWSorensenOHRandomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study GroupOsteoporos Int200011839110663363
   PubMed Web of Science ®Google Scholar
• ReginsterJYGilletPBen SedrineWDirect costs of hip fractures in patients over 60 years of age in BelgiumPharmacoeconomics1999155071410537967
   PubMed Web of Science ®Google Scholar
• ReginsterJYSarletNLejeuneEStrontium ranelate: a new treatment for postmenopausal osteoporosis with a dual mode of actionCurr Osteoporos Rep2005330416036099
   PubMedGoogle Scholar
• ReginsterJYSeemanEDe VernejoulMCStrontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) StudyJ Clin Endocrinol Metab20059028162215728210
   PubMed Web of Science ®Google Scholar
• RiggsBLHartmannLCSelective estrogen-receptor modulators – mechanisms of action and application to clinical practiceN Engl J Med20033486182912584371
   PubMed Web of Science ®Google Scholar
• RiggsBLHodgsonSFO’FallonWMEffect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosisN Engl J Med199032280292407957
   PubMed Web of Science ®Google Scholar
• RizzoliRGreenspanSLBoneG 3rdTwo-year results of once-weekly administration of alendronate 70mg for the treatment of postmenopausal osteoporosisJ Bone Miner Res20021719889612412806
   PubMed Web of Science ®Google Scholar
• RonkinSNorthingtonRBaracatEEndometrial effects of bazedoxifene acetate, a novel selective estrogen receptor modulator, in postmenopausal womenObstet Gynecol2005105139740415932835
   PubMed Web of Science ®Google Scholar
• RouxCPelissierCFechtenbaumJRandomized, double-masked, 2-year comparison of tibolone with 17beta-estradiol and norethindrone acetate in preventing postmenopausal bone lossOsteoporos Int200213241811991445
   PubMed Web of Science ®Google Scholar
• RubinCDPakCYAdams-HuetBSustained-release sodium fluoride in the treatment of the elderly with established osteoporosisArch Intern Med200116123253311606148
   PubMedGoogle Scholar
• RubinMRBilezikianJPNew anabolic therapies in osteoporosisEndocrinol Metab Clin North Am20033228530712699304
   PubMed Web of Science ®Google Scholar
• RymerJRobinsonJFogelmanIEffects of 8 years of treatment with tibolone 2.5mg daily on postmenopausal bone lossOsteoporos Int2001124788311446564
   PubMed Web of Science ®Google Scholar
• SchlaichCMinneHWBrucknerTReduced pulmonary function in patients with spinal osteoporotic fracturesOsteoporos Int1998826179797911
   PubMed Web of Science ®Google Scholar
• SelbyPPostmenopausal osteoporosisCurr Osteoporos Rep20042101616036090
   PubMedGoogle Scholar
• SheaBWellsGCranneyAMeta-analyses of therapies for postmenopausal osteoporosis. VII. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosisEndocr Rev200223552912202470
   PubMed Web of Science ®Google Scholar
• SleeperRBBondCRojas-FernandezCPsychotropic drugs and falls: New evidence pertaining to SSRI'sPharmacotherapy2000203081710730686
   PubMed Web of Science ®Google Scholar
• [Teriparatide]Teriparatide (forteo) for osteoporosisMed Lett Drugs Ther20034591012571538
   PubMed Web of Science ®Google Scholar
• ThiebaudDBiglerJMRenteriaSA 3-year study of prevention of postmenopausal bone loss: conjugated equine estrogens plus medroxyprogesterone acetate versus tiboloneClimacteric199812021011907945
   PubMedGoogle Scholar
• TilyardMWSpearsGFThomsonJTreatment of postmenopausal osteoporosis with calcitriol or calciumN Engl J Med1992326357621729617
   PubMed Web of Science ®Google Scholar
• TinettiMEWilliamsCSFalls, injuries due to falls, and the risk of admission to a nursing homeN Engl J Med19973371279849345078
   PubMed Web of Science ®Google Scholar
• TorgersonDJBell-SyerSEHormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trialsJAMA2001a2852891711401611
   PubMed Web of Science ®Google Scholar
• TorgersonDJBell-SyerSEHormone replacement therapy and prevention of vertebral fractures: a meta-analysis of randomised trialsBMC Musculoskelet Disord2001b2711716794
   PubMedGoogle Scholar
• TucciJRImportance of early diagnosis and treatment of osteoporosis to prevent fracturesAm J Manag Care200612S1819016686587
   PubMed Web of Science ®Google Scholar
• [USPSTF] US Preventive Services Task ForceHormone therapy for the prevention of chronic conditions in postmenopausal women: recommendations from the US Preventive Services Task ForceAnn Intern Med20051428556015897536
   PubMed Web of Science ®Google Scholar
• van WeelCVermeulenHvan den BoschWFalls, a community care perspectiveLancet19953451549517791442
   PubMed Web of Science ®Google Scholar
• WallachJInterpretation of diagnostic testsA synopsis of laboratory medicine1986Boston, MALittle, Brown & Co
   Google Scholar
• WellsGTugwellPSheaBMeta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal womenEndocr Rev2002235293912202468
   PubMed Web of Science ®Google Scholar
• [WGWHII] Writing Group for the Women's Health Initiative InvestigatorsRisks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative Randomized Controlled TrialJAMA20022883213312117397
   PubMed Web of Science ®Google Scholar
• [WHISC] Women's Health Initiative Steering CommitteeEffects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative Randomized Controlled TrialJAMA200429117011215082697
   PubMed Web of Science ®Google Scholar
• WickershamRMNovakKKNutrients and nutritional agentsDrug facts and comparisons2002St. Louis, MOWolters Kluwer Health, Inc.267
   Google Scholar
• WurzGTReadKCMarchisano-KarpmanCOspemifene inhibits the growth of dimethylbenzanthracene-induced mammary tumors in Sencar miceJ Steroid Biochem Mol Biol2005972304016153821
   PubMed Web of Science ®Google Scholar
• ZaidiMMoongaBSAbeECalcitonin and bone formation: a knockout full of surprisesJ Clin Invest200211017697112488426
   PubMed Web of Science ®Google Scholar
• ZimmermanSIGirmanCJBuieVCThe prevalence of osteoporosis in nursing home residentsOsteoporos Int19999151710367043
   PubMed Web of Science ®Google Scholar